Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
- Resource Type
- Article
- Authors
- Drayson, Mark T ; Bowcock, Stella; Planche, Tim; Iqbal, Gulnaz; Pratt, Guy; Yong, Kwee; Wood, Jill; Raynes, Kerry; Higgins, Helen; Dawkins, Bryony; Meads, David; Hulme, Claire T; Monahan, Irene; Karunanithi, Kamaraj; Dignum, Helen; Belsham, Edward; Neilson, Jeff; Harrison, Beth; Lokare, Anand; Campbell, Gavin; Hamblin, Michael; Hawkey, Peter; Whittaker, Anna C; Low, Eric; Dunn, Janet A
- Source
- In The Lancet Oncology December 2019 20(12):1760-1772
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045